Syngenta opens Gene Editing and Enabling Technology! Or will promote a variety of potential applications in the field of synthetic biology innovation
On June 9, 2024, Syngenta, one of the world's largest agricultural technology companies with a history of about 250 years and known as the "agrochemical carrier," announced that it will license selected gene editing and enabling technologies, breeding and seed production technologies for academic research worldwide. These technology licenses are available through its innovation collaboration platform, Shoots by Syngenta.
Syngenta will provide some of the intellectual property related to the optimized CRISPR-Cas12a and the gene-editing assisted breeding tool. Through CRISPR gene editing, improved plants can be delivered faster and more efficiently than natural or traditional breeding methods, and do not contain DNA from different species.
Syngenta's genome editing and enabling technologies and breeding technologies have a variety of potential applications in the field of synthetic biology, such as crop improvement, biopharmaceuticals, biofuels, environmental remediation, the food industry, biosensors, biomaterials, agricultural biotechnology, gene drive technology, synthetic ecology. These intellectual properties opened by Syngenta provide a powerful tool for the field of synthetic biology to help advance these applications and could lead to innovation in multiple fields, including agriculture, medicine, energy and the environment.
As a leader in this technological innovation, Syngenta scientists are constantly innovating to improve CRISPR-Cas gene editing technology. Syngenta scientists have engineered CRISPR Cas12a to significantly improve its efficiency and practicality, optimizing its function as a tool for crop improvement.
Gusui Wu, Head of Global seed research at Syngenta, said: "CRISPR technology has endless potential to advance crop innovation and create value for farmers. Expanding CRISPR technology in agriculture could transform the way we breed crops, accelerating the discovery and application of innovations that will provide growers with more productive and resilient crops. We are inviting universities and academic institutions from around the world to join us in promoting innovation and sustainable agriculture." .
The Shoots by Syngenta Global Innovation Collaboration Platform was established in 2023 to create partnerships to find solutions to the most complex challenges in food and agriculture. It brings together an external innovation ecosystem - including academics, research institutions and other entities - and Syngenta's network of more than 6,000 scientists worldwide to jointly develop solutions to mitigate climate change and enhance biodiversity.
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Bayer and Syngenta Score Consecutive Regulatory and Legal Wins in the U.S.
-
Syngenta Gets a New Boss
-
The Crop Protection Patent Cliff Is Here
-
The EPA reviews Syngenta's new product proposal, and the use of triticolobin is again attracting attention
-
Syngenta acquires Produtecnica, a distributor of agricultural inputs, to strengthen its agricultural services in Brazil
-
Syngenta launches its digital farming platform Cropwise® in Spain
-
Syngenta has announced a partnership with AI company InstaDeep to accelerate research on seed traits
-
Cyclobutrifluram was expanded to cucumber, melon and ginger in China
-
Syngenta's nicotinamide insecticide Flumetnicam received provisional ISO generic name approval
-
Syngenta's strategic shift in Brazil: closing 10 stores in the South and increasing investment in the Midwest
Recommend Reading
-
OCI Exits TDI Business and Joins South Korean Semiconductor Materials Cluster on the Same Day
-
CordenPharma Invests €80 Million to Raise Sterile Injectable Capacity to 500 Million Units Annually
-
ZPC Plans 1.2 Million-Tonne PDH Unit, Setting a New Global Licensing Record
-
Novo Nordisk’s Oral Wegovy Wins EU Approval as Weight-Loss Competition Shifts from Injections to Pills
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
-
Business Society September 29, 2026 Palm Oil Trend Analysis: Volatility
-
Business Society’s Market Outlook for Fuel Oil 180CST on September 10, 2026: Rising
-
Business Society September 29, 2026 PTA Trend Analysis: Volatility
-
Business Society’s Market Outlook for Petroleum Coke on September 10, 2026: Volatile
-
Palm Oil Market in September Experiences Volatile Decline